Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 22.1
1.94 %
$ 630 M
Market Cap
35.65
P/E
CSTL - DEPRECIATION & AMORTIZATION
Depreciation & Amortization CSTL - Castle Biosciences, Inc.
12.3 M
LAST VALUE
90.24%
2 YEAR CAGR
107.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR